Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    October 2017
  1. HOLMES B, Benavides-Serrato A, Freeman RS, Landon KA, et al
    mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  2. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
    Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  3. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  4. CHEN D, Fan Z, Rauh M, Buchfelder M, et al
    ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Oncogene. 2017;36:5593-5608.
    PubMed     Text format     Abstract available


    September 2017
  5. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  6. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
    DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  7. JAIN P, Fierst TM, Han HJ, Smith TE, et al
    CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  8. GUERRERO PA, Tchaicha JH, Chen Z, Morales JE, et al
    Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    July 2017
  9. YAN D, Kowal J, Akkari L, Schuhmacher AJ, et al
    Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  10. TAYLOR E, Alqadri N, Dodgson L, Mason D, et al
    MRL proteins cooperate with activated Ras in glia to drive distinct oncogenic outcomes.
    Oncogene. 2017;36:4311-4322.
    PubMed     Text format     Abstract available


  11. RODRIGUEZ-BLANCO J, Pednekar L, Penas C, Li B, et al
    Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  12. ARSLAN AD, Sassano A, Saleiro D, Lisowski P, et al
    Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
    Oncogene. 2017 Jul 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  13. YANG JM, Schiapparelli P, Nguyen HN, Igarashi A, et al
    Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
    Oncogene. 2017;36:3673-3685.
    PubMed     Text format     Abstract available


  14. CASTRO BA, Flanigan P, Jahangiri A, Hoffman D, et al
    Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Oncogene. 2017;36:3749-3759.
    PubMed     Text format     Abstract available


  15. CONDUIT SE, Ramaswamy V, Remke M, Watkins DN, et al
    A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  16. TIAN R, Wang J, Yan H, Wu J, et al
    Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  17. KESANAKURTI D, Maddirela D, Banasavadi-Siddegowda YK, Lai TH, et al
    A novel interaction of PAK4 with PPARgamma to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  18. ZHU C, Chrifi I, Mustafa D, van der Weiden M, et al
    CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  19. ZENG AL, Yan W, Liu YW, Wang Z, et al
    Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  20. KAWAUCHI D, Ogg RJ, Liu L, Shih DJH, et al
    Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  21. WALD JH, Hatakeyama J, Printsev I, Cuevas A, et al
    Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  22. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  23. LIU YS, Lin HY, Lai SW, Huang CY, et al
    MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  24. SCHROCK MS, Batar B, Lee J, Druck T, et al
    Wwox-Brca1 interaction: role in DNA repair pathway choice.
    Oncogene. 2017;36:2215-2227.
    PubMed     Text format     Abstract available


  25. NANDHU MS, Kwiatkowska A, Bhaskaran V, Hayes J, et al
    Tumor-derived fibulin-3 activates pro-invasive NF-kappaB signaling in glioblastoma cells and their microenvironment.
    Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  26. HU PS, Xia QS, Wu F, Li DK, et al
    NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  27. DEGUCHI S, Katsushima K, Hatanaka A, Shinjo K, et al
    Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  28. QI Q, Kang SS, Zhang S, Pham C, et al
    Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  29. SHIN CH, Robinson JP, Sonnen JA, Welker AE, et al
    HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  30. NATSUME A, Kato T, Kinjo S, Enomoto A, et al
    Girdin maintains the stemness of glioblastoma stem cells.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.
    PubMed     Text format    


  31. CHEN R, Duan J, Li L, Ma Q, et al
    mTOR promotes pituitary tumor development through activation of PTTG1.
    Oncogene. 2017;36:979-988.
    PubMed     Text format     Abstract available


  32. MASILAMANI AP, Ferrarese R, Kling E, Thudi NK, et al
    KLF6 depletion promotes NF-kappaB signaling in glioblastoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  33. VOLPIN F, Casaos J, Sesen J, Mangraviti A, et al
    Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  34. SAREDDY GR, Viswanadhapalli S, Surapaneni P, Suzuki T, et al
    Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  35. GARG N, Bakhshinyan D, Venugopal C, Mahendram S, et al
    CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  36. TALAMILLO A, Grande L, Ruiz-Ontanon P, Velasquez C, et al
    ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  37. HU L, Li X, Liu Q, Xu J, et al
    UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  38. XI G, Hayes E, Lewis R, Ichi S, et al
    CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-kappaB pathway in multidrug-resistant glioblastoma cells in vitro.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    


    August 2016
  39. HOU J, Deng Q, Zhou J, Zou J, et al
    CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
    Oncogene. 2016 Aug 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  40. BLANCHART A, Fernando R, Haring M, Assaife-Lopes N, et al
    Endogenous GABAA receptor activity suppresses glioma growth.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  41. CAI H, Liu X, Zheng J, Xue Y, et al
    Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  42. BANASAVADI-SIDDEGOWDA YK, Russell L, Frair E, Karkhanis VA, et al
    PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  43. HUANG MY, Xuan F, Liu W, Cui HJ, et al
    MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  44. MONDAL B, Patil V, Shwetha SD, Sravani K, et al
    Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.
    Oncogene. 2016 May 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  45. GHOOCHANI A, Schwarz MA, Yakubov E, Engelhorn T, et al
    MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  46. WEN J, Lee J, Malhotra A, Nahta R, et al
    WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  47. SHI X, Wang Q, Gu J, Xuan Z, et al
    SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  48. CAMPOS B, Olsen LR, Urup T, Poulsen HS, et al
    A comprehensive profile of recurrent glioblastoma.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  49. ELLERT-MIKLASZEWSKA A, Wisniewski P, Kijewska M, Gajdanowicz P, et al
    Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  50. ZHANG L, Zhang W, Li Y, Alvarez A, et al
    SHP-2-upregulated ZEB1 is important for PDGFRalpha-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2016
  51. LOPEZ-BERTONI H, Lal B, Michelson N, Guerrero-Cazares H, et al
    Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
    Oncogene. 2016 Feb 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  52. CHUA CY, Liu Y, Granberg KJ, Hu L, et al
    IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Oncogene. 2016;35:738-47.
    PubMed     Text format     Abstract available


  53. PEIXOTO P, Blomme A, Costanza B, Ronca R, et al
    HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.
    Oncogene. 2016 Feb 8. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    January 2016
  54. DEY A, Robitaille M, Remke M, Maier C, et al
    YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
    Oncogene. 2016 Jan 4. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  55. AUVERGNE R, Wu C, Connell A, Au S, et al
    PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.
    Oncogene. 2015 Nov 30. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  56. SCHULZE M, Fedorchenko O, Zink TG, Knobbe-Thomsen CB, et al
    Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.
    Oncogene. 2015 Nov 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  57. SARTORIUS CA, Hanna CT, Gril B, Cruz H, et al
    Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.
    Oncogene. 2015 Sep 28. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  58. TREPS L, Edmond S, Harford-Wright E, Galan-Moya EM, et al
    Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma.
    Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  59. GEREZ J, Tedesco L, Bonfiglio JJ, Fuertes M, et al
    RSUME inhibits VHL and regulates its tumor suppressor function.
    Oncogene. 2015;34:4855-66.
    PubMed     Text format     Abstract available


    August 2015
  60. PEREZ JG, Tran NL, Rosenblum MG, Schneider CS, et al
    The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
    Oncogene. 2015 Aug 24. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  61. YEN SY, Chen SR, Hsieh J, Li YS, et al
    Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion.
    Oncogene. 2015 Aug 10. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  62. LOPEZ-BERTONI H, Lal B, Li A, Caplan M, et al
    DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
    Oncogene. 2015;34:3994-4004.
    PubMed     Text format     Abstract available


  63. SIN WC, Aftab Q, Bechberger JF, Leung JH, et al
    Astrocytes promote glioma invasion via the gap junction protein connexin43.
    Oncogene. 2015 Jul 13. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  64. GARCIA I, Crowther AJ, Gama V, Miller CR, et al
    Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
    Oncogene. 2015;34:3881.
    PubMed     Text format    


    June 2015
  65. AHN BY, Saldanha-Gama RF, Rahn JJ, Hao X, et al
    Glioma invasion mediated by the p75 neurotrophin receptor (p75/CD271) requires regulated interaction with PDLIM1.
    Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    May 2015
  66. FRIEDMANN-MORVINSKI D, Bhargava V, Gupta S, Verma IM, et al
    Identification of therapeutic targets for glioblastoma by network analysis.
    Oncogene. 2015 May 11. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: